Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma

Clin Cancer Res. 2001 Jul;7(7):1946-51.

Abstract

Purpose: The EBV latent membrane protein-1 (LMP-1) is a multifunctional protein. Recently, the contribution of LMP-1 to the metastasis of nasopharyngeal carcinoma (NPC) has been suggested. Angiogenesis is a key step for metastasis. Thus, the association of LMP-1 to neovascularization of NPC was examined in this study.

Experimental design: The association of LMP-1 to angiogenesis in 39 patients with NPC was evaluated by immunohistochemical study, and then induction of angiogenic factors by LMP-1 was examined by ELISA and luciferase reporter assay.

Results: In an immunohistochemical study, the expression of LMP-1 was significantly correlated to microvessel counts (P = 0.0003), suggesting that LMP-1 may induce some angiogenic factors. Therefore, we studied the relationship between LMP-1 expression and interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF) expression by immunohistochemical analysis. IL-8, VEGF, and bFGF expression were correlated to microvessel counts, but only IL-8 expression was significantly correlated to LMP-1 expression (P < 0.0001). Transfection with LMP-1 expression plasmid induced IL-8 protein expression in C33A cells. The expression of LMP-1 transactivated IL-8 promoter, as demonstrated by IL-8 promoter luciferase reporter assay. Mutation of the nuclear factor kappaB responsive element in the IL-8 promoter region completely abolished transactivation by LMP-1, whereas mutation of the activator protein responsive element did not affect promoter activity.

Conclusion: These results suggested that LMP-1 induces expression of IL-8 through the nuclear factor kappaB binding site, which may contribute in part to angiogenesis in NPC.

MeSH terms

  • Angiogenesis Inducing Agents / analysis
  • Base Sequence
  • Binding Sites / genetics
  • Blood Vessels / pathology
  • Epstein-Barr Virus Infections / pathology
  • Epstein-Barr Virus Infections / virology
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / metabolism
  • Humans
  • Immunohistochemistry
  • Interleukin-8 / biosynthesis*
  • Interleukin-8 / genetics
  • Luciferases / genetics
  • Luciferases / metabolism
  • Mutation
  • NF-kappa B / metabolism
  • Nasopharyngeal Neoplasms / blood supply*
  • Nasopharyngeal Neoplasms / virology
  • Neovascularization, Pathologic / pathology*
  • Neovascularization, Pathologic / virology
  • Plasmids / genetics
  • Promoter Regions, Genetic / genetics
  • Protein Binding
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Transcription Factor AP-1 / metabolism
  • Transcriptional Activation
  • Tumor Cells, Cultured
  • Viral Matrix Proteins / biosynthesis*
  • Viral Matrix Proteins / genetics
  • von Willebrand Factor / analysis

Substances

  • Angiogenesis Inducing Agents
  • EBV-associated membrane antigen, Epstein-Barr virus
  • Interleukin-8
  • NF-kappa B
  • Recombinant Fusion Proteins
  • Transcription Factor AP-1
  • Viral Matrix Proteins
  • von Willebrand Factor
  • Luciferases